Game-Changer for Asymptomatic Alzheimer's Trials?

(MedPage Today) -- Blood tests to screen for amyloid-beta could cut the need for PET scans in half in asymptomatic Alzheimer's research trials, a British cohort study suggested.
To find 100 amyloid PET-positive, dementia-free older adults from...